Hyaluronic acid ester microspheres as a nasal delivery system for insulin
- 1 February 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 29 (1-2) , 133-141
- https://doi.org/10.1016/0168-3659(94)90129-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hyaluronane derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterizationInternational Journal of Pharmaceutics, 1992
- Intranasal InsulinClinical Pharmacokinetics, 1992
- Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal SubjectsDiabetic Medicine, 1992
- In vitro studies on biocompatibility of hyaluronic acid estersBiomaterials, 1991
- Investigation of the nasal absorption of biosynthetic human growth hormone in sheep—use of a bioadhesive microsphere delivery systemInternational Journal of Pharmaceutics, 1990
- Nasal administration of insulin using bioadhesive microspheres as a delivery systemJournal of Controlled Release, 1990
- Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone releaseJournal of Controlled Release, 1990
- Nasal administration of gentamicin using a novel microsphere delivery systemInternational Journal of Pharmaceutics, 1988
- Bioadhesive microspheres as a potential nasal drug delivery systemInternational Journal of Pharmaceutics, 1987
- Effects of Sodium Taurodihydrofusidate on Nasal Absorption of Insulin in SheepJournal of Pharmaceutical Sciences, 1987